Delivery Order SPE2DE21D7020-SPE2D625F1EM9
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1EM9Delivery Order
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier of advanced cardiovascular intervention technologies to federal healthcare systems. The award carries no set-aside designation, indicating open competition in the federal marketplace. The delivery order will be fulfilled at Boston Scientific's facility in Marlborough, Massachusetts. This award exemplifies Boston Scientific's significant presence within the Defense Health Agency's medical supply chain, where the company serves as a prime contractor providing specialized medical devices including cardiovascular intervention tools, stents, catheters, and diagnostic equipment to support federal healthcare agencies. As a major supplier to the Department of Defense Health Agency and Department of Veterans Affairs, Boston Scientific maintains multiple indefinite delivery vehicles and blanket purchase agreements that enable rapid response to federal healthcare requirements. The drug-coated balloon supplies under this delivery order support the DHA's mission to provide advanced medical technologies for interventional procedures across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 6/6/25 |